Comparison of Daily Home Hemodialysis (HD) With Conventional in Center HD in Terms of Patients Quality of Life and Clinical Outcomes (SeCoIA)
End Stage Renal Disease
About this trial
This is an interventional treatment trial for End Stage Renal Disease focused on measuring Home hemodialysis, Daily hemodialysis, Frequent hemodialysis
Eligibility Criteria
Inclusion Criteria:
- Male or female aged 18 years or over
- Patient who dated and signed the consent form
- Patient (s) affiliated to a Social Security scheme
- Interventional arm: patient who begins or will begin daily hemodialysis training (5, 6 or 7 times per week) at home.
- Comparator arm: prevalent or incident patient treated by conventional hemodialysis (3 times per week) and fitting with the matching criteria of an interventional patient included in the center
Exclusion Criteria:
- Patient with needs any help to walk (wheelchair, crutch, walker, cane ...)
- Patient with active neoplasia;
- Patient with predicted life expectancy of less than one year;
- Patient with significant reading or writing difficulties;
- Patient participating in a clinical trial or other interventional study; 6. Patient with history of mental instability, major cognitive impairment in the previous 5 years, or major psychiatric condition not adequately controlled or stable under pharmacological treatment
Sites / Locations
- Centre HospitalierRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Daily hemodialysis patients
Conventional hemodialysis patients
Description: End stage renal disease patients starting daily hemodialysis treatment. Interventions: Delivery of a connected pedometer / accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.
Description: End stage renal disease patients currently treated by conventional hemodialysis or starting conventional hemodialysis treatment. Interventions: Delivery of a connected pedometer / accelerometer and Quality Of Life and Restless Leg Syndrome questionnaires.